Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization

This study compared different magnetic resonance imaging (MRI) methods with Tl201 single photon emission computerized tomography (SPECT) and the “gold standard” for viability assessment, functional recovery after coronary artery bypass grafting (CABG). Twenty patients (64±7.3 years) with severely impaired left ventricular function (ejection fraction [EF] 28.6±8.7%) underwent MRI and SPECT before and 6 months after CABG. Wall-motion abnormalities were assessed by stress cine MRI using low-dose dobutamine. A segment with a nonreversible defect in Tl201-SPECT and a delayed enhancement (DE) in an area >50% of the entire segment, as well as an end-diastolic wall thickness <6 mm, was defined as nonviable. The mean postoperative EF (n=20) improved slightly from 28.6±8.7% to 32.2±12.4% (not significant). Using the Tl201-SPECT as the reference method, end-diastolic wall thickness, MRI-DE, and stress MRI showed high sensitivity of 94%, 93%, and 84%, respectively, but low specificities. Using the recovery of contractile function 6 months after CABG as the gold standard, MRI-DE showed an even higher sensitivity of 99%, end-diastolic wall thickness 96%, stress MRI 88%, and Tl201-SPECT 86%. MRI-DE showed advantages compared with the widely used Tl201-SPECT and all other MRI methods for predicting myocardial recovery after CABG.

[1]  M. Verani,et al.  Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function. , 1997, Circulation.

[2]  R. Kim,et al.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.

[3]  J Knuuti,et al.  Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience. , 2000, Radiology.

[4]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[5]  J. Sandstede Assessment of myocardial viability by MR imaging , 2002, European Radiology.

[6]  U. Sechtem,et al.  Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. , 1995, Circulation.

[7]  E. Erdmann,et al.  Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. , 1998, Journal of the American College of Cardiology.

[8]  T. Kaul,et al.  Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. , 1996, The Journal of thoracic and cardiovascular surgery.

[9]  H. Oswald,et al.  Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. , 2000, Circulation.

[10]  J. Sýkora,et al.  Attenuation correction improves the detection of viable myocardium by thallium-201 cardiac tomography in patients with previous myocardial infarction and left ventricular dysfunction , 1999, European Journal of Nuclear Medicine.

[11]  B. Schnackenburg,et al.  Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography , 2002, Circulation.

[12]  E. Fleck,et al.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. , 1999, Circulation.

[13]  M. Oudkerk,et al.  Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia , 2004, European Radiology.

[14]  D Hahn,et al.  Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability. , 2000, AJR. American journal of roentgenology.

[15]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[16]  R. Ehman,et al.  Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. , 1984, Radiology.

[17]  D. Berman,et al.  Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  I G Zubal,et al.  Extracardiac activity complicates quantitative cardiac SPECT imaging using a simultaneous transmission-emission approach. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  R O Bonow,et al.  Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. , 1998, Circulation.

[20]  R Härkönen,et al.  Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. , 1994, American heart journal.

[21]  A de Roos,et al.  MR imaging of acute myocardial infarction: value of Gd-DTPA. , 1988, AJR. American journal of roentgenology.

[22]  M. Oudkerk,et al.  Dobutamine stress MRI. Part II. Risk stratification with dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia , 2004, European Radiology.

[23]  F J Ten Cate,et al.  Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. , 1995, Circulation.

[24]  E. Erdmann,et al.  Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. , 1996, The American journal of cardiology.

[25]  J. Dahl,et al.  Diagnostik der Myokardvitalität bei chronischer Myokardischämie mit nuklearmedizinischen Verfahren , 1998, Zeitschrift für Kardiologie.

[26]  M. Reiser,et al.  Assessment of myocardial perfusion using multisection first-pass MRI and color-coded parameter maps: a comparison to 99mTc Sesta MIBI SPECT and systolic myocardial wall thickening analysis. , 1999, Magnetic resonance imaging.

[27]  H. Amthauer,et al.  Factors excercising an influence on recovery of hibernating myocardium after coronary artery bypass grafting. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  S. Maderwald,et al.  Steady-state free precession sequences in myocardial first-pass perfusion MR imaging: comparison with TurboFLASH imaging , 2004, European Radiology.

[29]  A. Roos,et al.  Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. , 1998, American heart journal.

[30]  T L Faber,et al.  Left ventricular function and perfusion from gated SPECT perfusion images: an integrated method. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  M. Verani,et al.  Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans. , 1999, Circulation.

[32]  Richard P. Lewis,et al.  Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Soci , 1995, Journal of the American College of Cardiology.

[33]  R. Hetzer,et al.  Decision-making in end-stage coronary artery disease: revascularization or heart transplantation? , 1997, The Annals of thoracic surgery.

[34]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[35]  U Sechtem,et al.  Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses. , 1994, European heart journal.

[36]  Th J A Kuijpers Dobutamine stress MRI , 2005 .

[37]  Richard P. Lewis,et al.  Guidelines for clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (committee on radionuclide imaging) — Developed in collaboration with the American S , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[38]  F. C. Dougherty,et al.  Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPA , 1986, Clinical cardiology.